{"id":"NCT00674609","sponsor":"Jazz Pharmaceuticals","briefTitle":"A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy","officialTitle":"A Double Blind, Randomized, Parallel Group, Placebo Controlled, Comparative Study of the Efficacy, Safety and Tolerability of Cannabis Based Medicine (CBM) Extracts in Patients With Cancer-related Pain.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-02","primaryCompletion":"2004-02","completion":"2004-03","firstPosted":"2008-05-08","resultsPosted":"2012-08-13","lastUpdate":"2023-05-03"},"enrollment":177,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Palliative Care","Pain","Cancer"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":["GW-4000-01"]},{"type":"DRUG","name":"Sativex®","otherNames":["GW-1000-02"]},{"type":"DRUG","name":"THC Alone","otherNames":["GW-2000-02","THC"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Sativex","type":"EXPERIMENTAL"},{"label":"THC Alone","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether Sativex® and GW-2000-02 are effective in the management of subjects with intractable cancer-related pain.","primaryOutcome":{"measure":"The Change in Mean Pain Numerical Rating Scale (NRS) Score From Baseline to the End of the Treatment.","timeFrame":"2 weeks: baseline - end of week 2 (last 3 days of treatment)","effectByArm":[{"arm":"Sativex","deltaMin":-1.32,"sd":1.64},{"arm":"THC Alone","deltaMin":-0.93,"sd":1.15},{"arm":"Placebo","deltaMin":-0.73,"sd":1.51}],"pValues":[{"comp":"OG000 vs OG002","p":"0.014"},{"comp":"OG001 vs OG002","p":"0.244"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":16},"locations":{"siteCount":1,"countries":["United Kingdom"]},"refs":{"pmids":["19896326"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":60},"commonTop":["Somnolence","Nausea","Dizziness","Neoplasm progression NOS","Vomiting"]}}